Radiographic and clinical outcome of tibial plateau fractures treated with bone allograft.


Journal

Archives of orthopaedic and trauma surgery
ISSN: 1434-3916
Titre abrégé: Arch Orthop Trauma Surg
Pays: Germany
ID NLM: 9011043

Informations de publication

Date de publication:
May 2023
Historique:
received: 11 04 2022
accepted: 17 04 2022
medline: 19 4 2023
pubmed: 10 5 2022
entrez: 9 5 2022
Statut: ppublish

Résumé

To determine the clinical outcome of patients who had been treated with bone allografts during open reduction and internal fixation (ORIF) of tibial head fractures. Patients who suffered a medial, lateral, or bicondylar fracture of the tibial plateau and underwent surgical treatment by open reduction and internal fixation (ORIF) using human femoral head bone allografts were included. Patients were invited to provide information for the following: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), EuroQol Five Dimension score (EQ-5D), Lower Extremity Functional Scale (LEFS) and Parker Mobility Score. Bone mineral density (BMD) of the allograft area and the healthy human bone tissue were measured by quantitative computed tomography. A total of 22 patients with a mean follow-up time of 2.88 ± 2.46 years were included in our study. The most common fractures observed in this study were classified as Schatzker II (11 patients, 50.0%) or AO/OTA 41.B3 (12 patients, 54.5%) fractures. Postoperative WOMAC total was 13.0 (IQR = 16.3, range 0-33). Median quality of life (EQ-5D) score was 0.887 ± 0.121 (range 0.361-1.000). Median Lower Extremity Functional Scale (LEFS) score was 57.5 ± 19.0 (range 33-79). Mean Parker Mobility Score was 9 (range 6-9). Median bone mineral density (BMD) for the whole group was 300.04 ± 226.02 mg/cm Based on WOMAC scores, LEFS, ambulatory status, and quality of life findings, it can be concluded that following tibial head ORIF with allograft bone patients has promising results.

Sections du résumé

BACKGROUND BACKGROUND
To determine the clinical outcome of patients who had been treated with bone allografts during open reduction and internal fixation (ORIF) of tibial head fractures.
METHODS METHODS
Patients who suffered a medial, lateral, or bicondylar fracture of the tibial plateau and underwent surgical treatment by open reduction and internal fixation (ORIF) using human femoral head bone allografts were included. Patients were invited to provide information for the following: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), EuroQol Five Dimension score (EQ-5D), Lower Extremity Functional Scale (LEFS) and Parker Mobility Score. Bone mineral density (BMD) of the allograft area and the healthy human bone tissue were measured by quantitative computed tomography.
RESULTS RESULTS
A total of 22 patients with a mean follow-up time of 2.88 ± 2.46 years were included in our study. The most common fractures observed in this study were classified as Schatzker II (11 patients, 50.0%) or AO/OTA 41.B3 (12 patients, 54.5%) fractures. Postoperative WOMAC total was 13.0 (IQR = 16.3, range 0-33). Median quality of life (EQ-5D) score was 0.887 ± 0.121 (range 0.361-1.000). Median Lower Extremity Functional Scale (LEFS) score was 57.5 ± 19.0 (range 33-79). Mean Parker Mobility Score was 9 (range 6-9). Median bone mineral density (BMD) for the whole group was 300.04 ± 226.02 mg/cm
CONCLUSION CONCLUSIONS
Based on WOMAC scores, LEFS, ambulatory status, and quality of life findings, it can be concluded that following tibial head ORIF with allograft bone patients has promising results.

Identifiants

pubmed: 35534713
doi: 10.1007/s00402-022-04461-x
pii: 10.1007/s00402-022-04461-x
pmc: PMC9085366
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2447-2454

Informations de copyright

© 2022. The Author(s).

Références

J Bone Joint Surg Am. 2010 Jul 7;92(7):1652-60
pubmed: 20595573
Injury. 2011 Sep;42 Suppl 2:S30-4
pubmed: 21839446
Int J Surg. 2015 Jun;18:184-90
pubmed: 25937154
J Bone Joint Surg Am. 2020 Feb 5;102(3):179-193
pubmed: 31809394
J Orthop Trauma. 2014 Feb;28(2):97-102
pubmed: 23695375
Injury. 2020 Feb;51(2):395-399
pubmed: 31668574
Clin Orthop Relat Res. 1979 Jan-Feb;(138):94-104
pubmed: 445923
Calcif Tissue Int. 1997 Feb;60(2):194-9
pubmed: 9056170
Injury. 2010 Feb;41(2):173-8
pubmed: 19744652
J Clin Epidemiol. 2004 Oct;57(10):1025-32
pubmed: 15528053
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
J Clin Med. 2020 Apr 01;9(4):
pubmed: 32244592
Eur J Orthop Surg Traumatol. 2017 Jul;27(5):665-671
pubmed: 27722903
Arch Orthop Trauma Surg. 2017 Jun;137(6):755-760
pubmed: 28391428
Br J Rheumatol. 1997 May;36(5):551-9
pubmed: 9189057
Injury. 2008 Oct;39(10):1106-12
pubmed: 18656870
J Am Acad Orthop Surg. 2005 Jan-Feb;13(1):77-86
pubmed: 15712985
J Orthop Trauma. 2001 Jun-Jul;15(5):312-20
pubmed: 11433134
Skeletal Radiol. 2012 Mar;41(3):299-304
pubmed: 21509434
J Trauma Manag Outcomes. 2013 Sep 11;7(1):7
pubmed: 24025650
Biopreserv Biobank. 2016 Aug;14(4):319-23
pubmed: 27028037
J Orthop Res. 2006 Nov;24(11):2080-6
pubmed: 16944472
J Am Acad Orthop Surg. 1995 Mar;3(2):86-94
pubmed: 10790657
J Biomater Appl. 2011 Nov;26(4):491-506
pubmed: 20819915
J Orthop Trauma. 2002 May;16(5):323-9
pubmed: 11972075
J Rheumatol. 1988 Dec;15(12):1833-40
pubmed: 3068365
Int Orthop. 2012 Mar;36(3):633-41
pubmed: 22048753
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Qual Life Res. 2015 Feb;24(2):405-10
pubmed: 25108549
Ir J Med Sci. 2012 Jun;181(2):247-52
pubmed: 22228265
Injury. 2016 Jul;47(7):1483-7
pubmed: 27178768
Cell Tissue Bank. 2013 Sep;14(3):375-80
pubmed: 22986931
Arch Orthop Trauma Surg. 2010 Jan;130(1):143-9
pubmed: 19529951
J Trauma. 2010 Apr;68(4):980-3
pubmed: 20386289
Calcif Tissue Int. 1996 Mar;58(3):135-43
pubmed: 8852567
BMC Musculoskelet Disord. 2012 Mar 24;13:44
pubmed: 22443362
J Orthop Trauma. 2003 May;17(5):346-52
pubmed: 12759639
Injury. 2013 Jan;44 Suppl 1:S86-94
pubmed: 23351879
J Bone Joint Surg Br. 1993 Sep;75(5):797-8
pubmed: 8376443
J Orthop Trauma. 2008 Sep;22(8 Suppl):S83-90
pubmed: 18753895
Cell Tissue Bank. 2013 Sep;14(3):395-400
pubmed: 22936498
Phys Ther. 1999 Apr;79(4):371-83
pubmed: 10201543
Injury. 2018 Dec;49(12):2252-2263
pubmed: 30526924

Auteurs

Sarah Meiser (S)

Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Rohit Arora (R)

Dept. of Orthopaedics and Traumatology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Johannes Petersen (J)

Dept. of Radiology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
Klinikum Freising, Radiologie Klinikum Freising, Alois-Steinecker-Straße 18, 85354, Freising, Germany.

Alexander Keiler (A)

Dept. of Orthopaedics and Traumatology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Michael C Liebensteiner (MC)

Dept. of Orthopaedics and Traumatology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Johannes Dominikus Pallua (JD)

Dept. of Orthopaedics and Traumatology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Alexander Wurm (A)

Dept. of Orthopaedics and Traumatology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. alexander.wurm@i-med.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH